Exact Mass: 694.2374

Exact Mass Matches: 694.2374

Found 54 metabolites which its exact mass value is equals to given mass value 694.2374, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methyl 3,4,5-trimethoxycinnamate [arabinosyl-(1->3)-[glucosyl-(1->6)]-glucosyl] ester

4-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoic acid

C29H42O19 (694.232)


Methyl 3,4,5-trimethoxycinnamate [arabinosyl-(1->3)-[glucosyl-(1->6)]-glucosyl] ester is found in pulses. Methyl 3,4,5-trimethoxycinnamate [arabinosyl-(1->3)-[glucosyl-(1->6)]-glucosyl] ester is a constituent of soybean molasses (Glycine sp.) Constituent of soybean molasses (Glycine species). Methyl 3,4,5-trimethoxycinnamate [arabinosyl-(1->3)-[glucosyl-(1->6)]-glucosyl] ester is found in pulses.

   

Jaspamide H

Jaspamide H

C35H43BrN4O6 (694.2366)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.

   

Jaspamide J

Jaspamide J

C35H43BrN4O6 (694.2366)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.

   

Sanggenon G

(2S) -2alpha- (2,4-Dihydroxyphenyl) -5,7-dihydroxy-6- [ (1S) -3- (4-methyl-3-pentenyl) -5beta- (2,4-dihydroxyphenyl) -6alpha- (2,4-dihydroxybenzoyl) -2-cyclohexene-1beta-yl ] -2,3-dihydro-4H-1-benzopyran-4-one

C40H38O11 (694.2414)


Sanggenon G is a member of flavanones. Sanggenon G is a natural product found in Morus alba with data available.

   

Kuwanon O

Kuwanon O

C40H38O11 (694.2414)


Kuwanon O is a natural product found in Morus lhou and Morus alba with data available.

   
   

6-O-(2-acetyl-3--alpha-L-rhamnopyranosyl)aucubin

6-O-(2-acetyl-3--alpha-L-rhamnopyranosyl)aucubin

C33H42O16 (694.2473)


   

jaspamide F

jaspamide F

C35H43BrN4O6 (694.2366)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.

   

(8R,8R,8R,8R,9R,9S)-bicubebin A

(8R,8R,8R,8R,9R,9S)-bicubebin A

C40H38O11 (694.2414)


   

Buddlejoside A2

Buddlejoside A2

C33H42O16 (694.2473)


   

SCHEMBL13233446

SCHEMBL13233446

C40H38O11 (694.2414)


   

3-Ac,3,4-di-Me ether-Acteoside

3-Ac,3,4-di-Me ether-Acteoside

C33H42O16 (694.2473)


   

6-O-Acetylmartynoside|wiedemannioside A

6-O-Acetylmartynoside|wiedemannioside A

C33H42O16 (694.2473)


   
   

2-O-acetylmartynoside

2-O-acetylmartynoside

C33H42O16 (694.2473)


   

8E-decaene-4,6-diyn-1-O-beta-D-apiofuranosyl(1->6)-beta-D-glucopyranoside peracetate

8E-decaene-4,6-diyn-1-O-beta-D-apiofuranosyl(1->6)-beta-D-glucopyranoside peracetate

C33H42O16 (694.2473)


   

sinapyl alcohol 9-O-feruloyl-4-O-alpha-rhamnopyranosyl-(1->2)-beta-glucopyranoside|solargin I

sinapyl alcohol 9-O-feruloyl-4-O-alpha-rhamnopyranosyl-(1->2)-beta-glucopyranoside|solargin I

C33H42O16 (694.2473)


   

jaspamide M|jasplakinolide M

jaspamide M|jasplakinolide M

C35H43BrN4O6 (694.2366)


   

Methyl 3,4,5-trimethoxycinnamate [arabinosyl-(1->3)-[glucosyl-(1->6)]-glucosyl] ester

4-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C29H42O19 (694.232)


   

Foxy-5

Foxy-5

C26H42N6O12S2 (694.2302)


C274 - Antineoplastic Agent > C2196 - Antimetastatic Agent

   

Jaspamide M

Jaspamide M

C35H43BrN4O6 (694.2366)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.

   

Sarcodonin-delta

Sarcodonin-delta

C35H38N2O13 (694.2374)


A natural product found particularly in Sarcodon scabrosus and Hydnellum suaveolens.

   

Vevorisertib (trihydrochloride)

Vevorisertib (trihydrochloride)

C35H41Cl3N8O (694.2469)


Vevorisertib (ARQ 751) trihydrochloride is a selective, allosteric, pan-AKT and AKT1-E17K mutant inhibitors. Vevorisertib trihydrochloride potently inhibit phosphorylation of AKT. Vevorisertib trihydrochloride has Kd values of 1.2 nM and 8.6 nM for AKT1 and AKT1-E17K, respectively. Vevorisertib trihydrochloride has IC50 values of 0.55, 0.81, and 1.3 nM for AKT1, AKT2, and AKT3, respectively. Vevorisertib trihydrochloride can be used for the research of cancer[1].

   

4-{[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

4-{[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

4-{[3-(acetyloxy)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

4-{[3-(acetyloxy)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

4-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

4-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

(4r,7r,10s,15e,17r,19s)-7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,15,17,19-pentamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

(4r,7r,10s,15e,17r,19s)-7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,15,17,19-pentamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

C35H43BrN4O6 (694.2366)


   

(3r)-3-{2-[(2r)-2-{[(3r)-3-{2-[(2r)-2-{[(3s)-3,4-dihydroxybutanoyl]oxy}propyl]-4,6-dihydroxybenzoyloxy}butanoyl]oxy}propyl]-6-hydroxy-4-methoxybenzoyloxy}butanoic acid

(3r)-3-{2-[(2r)-2-{[(3r)-3-{2-[(2r)-2-{[(3s)-3,4-dihydroxybutanoyl]oxy}propyl]-4,6-dihydroxybenzoyloxy}butanoyl]oxy}propyl]-6-hydroxy-4-methoxybenzoyloxy}butanoic acid

C33H42O16 (694.2473)


   

(2s)-6-[(1s,5r,6s)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methylpent-3-en-1-yl)cyclohex-2-en-1-yl]-2-(2,5-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

(2s)-6-[(1s,5r,6s)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methylpent-3-en-1-yl)cyclohex-2-en-1-yl]-2-(2,5-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

C40H38O11 (694.2414)


   

(2s,3r,4r,5r,6r)-6-{[(1s,4ar,5s,7as)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-5-(acetyloxy)-4-hydroxy-2-methyloxan-3-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

(2s,3r,4r,5r,6r)-6-{[(1s,4ar,5s,7as)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-5-(acetyloxy)-4-hydroxy-2-methyloxan-3-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

(2s)-6-[(1s,5r,6s)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methylpent-3-en-1-yl)cyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

(2s)-6-[(1s,5r,6s)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methylpent-3-en-1-yl)cyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

C40H38O11 (694.2414)


   

(2r,3r,4r,5r,6r)-4-{[(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2r,3r,4r,5r,6r)-4-{[(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

(2e)-3-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2e)-3-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

5-{[(3r,4r,5s)-4-(2h-1,3-benzodioxol-5-ylmethyl)-5-{[(2r,3r,4r)-3,4-bis(2h-1,3-benzodioxol-5-ylmethyl)oxolan-2-yl]oxy}oxolan-3-yl]methyl}-2h-1,3-benzodioxole

5-{[(3r,4r,5s)-4-(2h-1,3-benzodioxol-5-ylmethyl)-5-{[(2r,3r,4r)-3,4-bis(2h-1,3-benzodioxol-5-ylmethyl)oxolan-2-yl]oxy}oxolan-3-yl]methyl}-2h-1,3-benzodioxole

C40H38O11 (694.2414)


   

(1s,10r)-6-[2,3-bis(acetyloxy)-4',5,6-trihydroxy-[1,1'-biphenyl]-4-yl]-10,13-bis[(2s)-butan-2-yl]-14-hydroxy-12-methoxy-11-oxo-2,9-dioxa-1,12-diazatricyclo[8.4.0.0³,⁸]tetradeca-3,5,7,13-tetraen-1-ium-1-olate

(1s,10r)-6-[2,3-bis(acetyloxy)-4',5,6-trihydroxy-[1,1'-biphenyl]-4-yl]-10,13-bis[(2s)-butan-2-yl]-14-hydroxy-12-methoxy-11-oxo-2,9-dioxa-1,12-diazatricyclo[8.4.0.0³,⁸]tetradeca-3,5,7,13-tetraen-1-ium-1-olate

C35H38N2O13 (694.2374)


   

(2e)-3-(4-{[(2s,4s,5s)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2e)-3-(4-{[(2s,4s,5s)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

(2r,3r,4r,5r,6r)-4-{[(2s,3r,4r,5r,6s)-3-(acetyloxy)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2r,3r,4r,5r,6r)-4-{[(2s,3r,4r,5r,6s)-3-(acetyloxy)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

(2r,3r,4r,5r,6r)-4-{[(2s,3r,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2r,3r,4r,5r,6r)-4-{[(2s,3r,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

[3,4-bis(acetyloxy)-5-{[3,4,5-tris(acetyloxy)-6-(dec-8-en-4,6-diyn-1-yloxy)oxan-2-yl]methoxy}oxolan-3-yl]methyl acetate

[3,4-bis(acetyloxy)-5-{[3,4,5-tris(acetyloxy)-6-(dec-8-en-4,6-diyn-1-yloxy)oxan-2-yl]methoxy}oxolan-3-yl]methyl acetate

C33H42O16 (694.2473)


   

2-(3-{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

2-(3-{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

C40H38O11 (694.2414)


   

5-(acetyloxy)-4-hydroxy-6-{[7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-2-methyloxan-3-yl 3-(4-methoxyphenyl)prop-2-enoate

5-(acetyloxy)-4-hydroxy-6-{[7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-2-methyloxan-3-yl 3-(4-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

(2r,3r,4r,5s,6s)-2-{[(1s,4ar,5s,7as)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-3-(acetyloxy)-5-hydroxy-6-methyloxan-4-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

(2r,3r,4r,5s,6s)-2-{[(1s,4ar,5s,7as)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-3-(acetyloxy)-5-hydroxy-6-methyloxan-4-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

4-(3-bromo-4-hydroxyphenyl)-6,12-dihydroxy-7-(1h-indol-3-ylmethyl)-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

4-(3-bromo-4-hydroxyphenyl)-6,12-dihydroxy-7-(1h-indol-3-ylmethyl)-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

C35H43BrN4O6 (694.2366)


   

(2r)-2-{3-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl}-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

(2r)-2-{3-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl}-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

C40H38O11 (694.2414)


   

(7r,10s,13s,15z,17s,18r)-4-(3-bromo-4-hydroxyphenyl)-6,12-dihydroxy-7-(1h-indol-3-ylmethyl)-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

(7r,10s,13s,15z,17s,18r)-4-(3-bromo-4-hydroxyphenyl)-6,12-dihydroxy-7-(1h-indol-3-ylmethyl)-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

C35H43BrN4O6 (694.2366)


   

(4r,7r,10s,13s,15e,17r,19s)-7-[(2-bromo-1h-indol-3-yl)methyl]-6,9,12-trihydroxy-4-(4-hydroxyphenyl)-10,13,15,17,19-pentamethyl-1-oxa-5,8,11-triazacyclononadeca-5,8,11,15-tetraen-2-one

(4r,7r,10s,13s,15e,17r,19s)-7-[(2-bromo-1h-indol-3-yl)methyl]-6,9,12-trihydroxy-4-(4-hydroxyphenyl)-10,13,15,17,19-pentamethyl-1-oxa-5,8,11-triazacyclononadeca-5,8,11,15-tetraen-2-one

C35H43BrN4O6 (694.2366)


   

3-[2-(2-{[3-(2-{2-[(3,4-dihydroxybutanoyl)oxy]propyl}-4,6-dihydroxybenzoyloxy)butanoyl]oxy}propyl)-6-hydroxy-4-methoxybenzoyloxy]butanoic acid

3-[2-(2-{[3-(2-{2-[(3,4-dihydroxybutanoyl)oxy]propyl}-4,6-dihydroxybenzoyloxy)butanoyl]oxy}propyl)-6-hydroxy-4-methoxybenzoyloxy]butanoic acid

C33H42O16 (694.2473)


   

(1r,10r)-6-[2,3-bis(acetyloxy)-4',5,6-trihydroxy-[1,1'-biphenyl]-4-yl]-10,13-bis[(2s)-butan-2-yl]-14-hydroxy-12-methoxy-11-oxo-2,9-dioxa-1,12-diazatricyclo[8.4.0.0³,⁸]tetradeca-3,5,7,13-tetraen-1-ium-1-olate

(1r,10r)-6-[2,3-bis(acetyloxy)-4',5,6-trihydroxy-[1,1'-biphenyl]-4-yl]-10,13-bis[(2s)-butan-2-yl]-14-hydroxy-12-methoxy-11-oxo-2,9-dioxa-1,12-diazatricyclo[8.4.0.0³,⁸]tetradeca-3,5,7,13-tetraen-1-ium-1-olate

C35H38N2O13 (694.2374)


   

(2s)-2-{3-[(1s,5r,6s)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl}-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

(2s)-2-{3-[(1s,5r,6s)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl}-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one

C40H38O11 (694.2414)


   

3-(acetyloxy)-5-hydroxy-2-{[7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-6-methyloxan-4-yl 3-(4-methoxyphenyl)prop-2-enoate

3-(acetyloxy)-5-hydroxy-2-{[7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-5-yl]oxy}-6-methyloxan-4-yl 3-(4-methoxyphenyl)prop-2-enoate

C33H42O16 (694.2473)


   

[(3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2r,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(8e)-dec-8-en-4,6-diyn-1-yloxy]oxan-2-yl]methoxy}oxolan-3-yl]methyl acetate

[(3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2r,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(8e)-dec-8-en-4,6-diyn-1-yloxy]oxan-2-yl]methoxy}oxolan-3-yl]methyl acetate

C33H42O16 (694.2473)


   

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-5-{[3,4-bis(2h-1,3-benzodioxol-5-ylmethyl)oxolan-2-yl]oxy}oxolan-3-yl]methyl}-2h-1,3-benzodioxole

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-5-{[3,4-bis(2h-1,3-benzodioxol-5-ylmethyl)oxolan-2-yl]oxy}oxolan-3-yl]methyl}-2h-1,3-benzodioxole

C40H38O11 (694.2414)